Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic Site
{{output}}
Colorectal cancer (CRC) patients are frequently diagnosed with metastases to the peritoneal cavity. These patients have a dismal prognosis and only limited therapeutical benefits. Solid tumors, including CRC, often display elevated levels of sialylated glycan ... ...